中國春來(01969.HK)獲授20億人幣信貸支持服務
中國春來(01969.HK)公布,其併表聯屬實體河南商丘春來教育集團與中國銀行南京分行訂立戰略合作協議。
據此,中國銀行擬將為集團學校的主要合作銀行,且中國銀行將為集團的學校提供各種金融服務,包括向集團的學校提供20億元人民幣的信貸支持服務(待滿足貸款條件的若干標準後及須經中國銀行進一步批准)用於校園建設和校園設備升級;其他中介服務(如結算及跨境金融服務);為集團的員工提供個性化金融服務(如存款、貸款、結算及理財等);以及為集團內各成員公司提供財務諮詢(包括但不限於信息諮詢、商業管理、投融資及其他相關領域)服務。集團的學校亦擬將優先選擇中國銀行提供工資、福利等支付服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.